Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome
Veronica Marrella, Pietro Luigi Poliani, Anna Casati, Francesca Rucci, Laura Frascoli, Marie-Lise Gougeon, Brigitte Lemercier, Marita Bosticardo, Maria Ravanini, Manuela Battaglia, Maria Grazia Roncarolo, Marina Cavazzana-Calvo, Fabio Facchetti, Luigi D. Notarangelo, Paolo Vezzoni, Fabio Grassi, Anna Villa
Veronica Marrella, Pietro Luigi Poliani, Anna Casati, Francesca Rucci, Laura Frascoli, Marie-Lise Gougeon, Brigitte Lemercier, Marita Bosticardo, Maria Ravanini, Manuela Battaglia, Maria Grazia Roncarolo, Marina Cavazzana-Calvo, Fabio Facchetti, Luigi D. Notarangelo, Paolo Vezzoni, Fabio Grassi, Anna Villa
View: Text | PDF
Research Article

A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome

  • Text
  • PDF
Abstract

Rag enzymes are the main players in V(D)J recombination, the process responsible for rearrangement of TCR and Ig genes. Hypomorphic Rag mutations in humans, which maintain partial V(D)J activity, cause a peculiar SCID associated with autoimmune-like manifestations, Omenn syndrome (OS). Although a deficient ability to sustain thymopoiesis and to produce a diverse T and B cell repertoire explains the increased susceptibility to severe infections, the molecular and cellular mechanisms underlying the spectrum of clinical and immunological features of OS remain poorly defined. In order to better define the molecular and cellular pathophysiology of OS, we generated a knockin murine model carrying the Rag2 R229Q mutation previously described in several patients with OS and leaky forms of SCID. These Rag2R229Q/R229Q mice showed oligoclonal T cells, absence of circulating B cells, and peripheral eosinophilia. In addition, activated T cells infiltrated gut and skin, causing diarrhea, alopecia, and, in some cases, severe erythrodermia. These findings were associated with reduced thymic expression of Aire and markedly reduced numbers of naturally occurring Tregs and NKT lymphocytes. In conclusion, Rag2R229Q/R229Q mice mimicked most symptoms of human OS; our findings support the notion that impaired immune tolerance and defective immune regulation are involved in the pathophysiology of OS.

Authors

Veronica Marrella, Pietro Luigi Poliani, Anna Casati, Francesca Rucci, Laura Frascoli, Marie-Lise Gougeon, Brigitte Lemercier, Marita Bosticardo, Maria Ravanini, Manuela Battaglia, Maria Grazia Roncarolo, Marina Cavazzana-Calvo, Fabio Facchetti, Luigi D. Notarangelo, Paolo Vezzoni, Fabio Grassi, Anna Villa

×

Figure 2

Histological analysis of Rag2R229Q/R229Q mice.

Options: View larger image (or click on image) Download as PowerPoint
Histological analysis of Rag2R229Q/R229Q mice.
               
(A) Pheno...
(A) Phenotypic aspect of a 3-month-old Rag2R229Q/R229Q mouse, showing severe alopecia and skin erythrodermia. (B) Skin biopsy revealed marked dermal inflammation (top) composed of CD3+ lymphocytes (bottom left) and containing numerous eosinophils (bottom right). Original magnification, ×10 (top); ×20 (bottom). (C) Similarly, the gut showed dense inflammatory infiltration (left), mainly composed of CD3+ cells (right). Original magnification, ×20. (D and E) Comparison between thymic tissue from age-matched 6-week-old Rag2+/+ and Rag2R229Q/R229Q mice: the normal corticomedullary differentiation observed in Rag2+/+ thymus (D), as highlighted by the anti–cytokeratin 5 immunostaining (D, inset), was absent in the Rag2R229Q/R229Q mouse (E and inset). Original magnification, ×4 (D and E). (F) B220 immunostaining showed B follicles (b) and paracortical areas (p) in Rag2+/+ mice (left) in contrast to the abnormal architecture and severe depletion of B cells observed in Rag2R229Q/R229Q mice (right). Original magnification, ×4. (G) Nodal parenchyma from the Rag2R229Q/R229Q (left) shows admixture of histiocytes, large activated lymphoid cells (arrow), and eosinophils (arrowhead); most lymphoid cells were CD3+ lymphocytes (top right) that expressed the activation antigen CD30 (bottom right). Original magnification, ×20 (left); ×40 (right).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts